Company Profiles

driven by the PitchBook Platform

HyperBranch Medical Technology

Description

Developer of biosurgical devices designed to reduce the morbidity and mortality of patients undergoing surgery. The company's biosurgical devices provide OcuSeal liquid ocular bandage for direct application on the surface of the eye, Dura Sealant, which is used as an aid in dural repair in cases of cranial and spinal surgeries and tunable hydrogels which confer material properties of biocompatibility with superior tissue adherence, strength and durability, enabling patients to recover faster in cases of tissue damage.

2003

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$2M

Latest Deal Amount

$21.8M

Total Amount Raised

Description

Developer of biosurgical devices designed to reduce the morbidity and mortality of patients undergoing surgery. The company's biosurgical devices provide OcuSeal liquid ocular bandage for direct application on the surface of the eye, Dura Sealant, which is used as an aid in dural repair in cases of cranial and spinal surgeries and tunable hydrogels which confer material properties of biocompatibility with superior tissue adherence, strength and durability, enabling patients to recover faster in cases of tissue damage.

Website:

www.hyperbranch.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Surgical Devices

Primary Office

800-12 Capitola Drive Durham, NC 27713United States +1 (919) 433-3325
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore HyperBranch Medical Technology's full profile, request a free trial.

    HyperBranch Medical Technology Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    HyperBranch Medical Technology Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    HyperBranch Medical Technology Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Durham CapitalLender/Debt ProviderMinority000 0000000 0000
    H.I.G. BioVenturesVenture CapitalMinority000 0000000 0000
    The Aurora FundsVenture CapitalMinority000 0000000 0000
    Durham Capital Lender/Debt Provider
    H.I.G. BioVentures Venture Capital
    The Aurora Funds Venture Capital

    HyperBranch Medical Technology Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Jeffrey ClarkBoard of Director, Chief Executive Officer & Chief Operating Officer
    Stuart RogersVice President, Global Sales & Marketing
    Jeffrey Clark Board of Director, Chief Executive Officer & Chief Operating Officer
    Stuart Rogers Vice President, Global Sales & Marketing

    HyperBranch Medical Technology Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Aaron DavidsonH.I.G. BioVenturesCo-Head & Managing Director000 0000
    Christopher Kroeger MDThe Aurora FundsPartner000 0000
    Jefferson ClarkThe Aurora FundsCo-Founder & Managing General Partner000 0000
    Michael Wasserman Ph.DH.I.G. BioVenturesManaging Director000 0000
    Robert WhiteSelfBoard Member000 0000
    Aaron Davidson Co-Head & Managing Director H.I.G. BioVentures
    Christopher Kroeger MD Partner The Aurora Funds
    Jefferson Clark Co-Founder & Managing General Partner The Aurora Funds
    Michael Wasserman Ph.D Managing Director H.I.G. BioVentures
    Robert White Board Member Self
    Request full access to PitchBook